The Effect of the Type of Conduit-duct Anastomosis Technique on the Postoperative Course in Patients Undergoing Liver Transplantation
A Prospective Randomized Study to Evaluate the Effect of the Type of Conduit-duct Anastomosis Using the Single/continuous Suture Technique on the Postoperative Course in Patients Undergoing Liver Transplantation from a Deceased Donor.
1 other identifier
interventional
284
1 country
1
Brief Summary
The main objective of the trial is to compare the effect of two end-to-end duct-to-duct anastomosis surgical techniques using the continuous suture method versus interrupted method (control group) on reducing the risk of bile leakages in the 90-day follow-up period after liver transplantation and other postoperative complications resulting from them i.e.: the occurrence of a critical stenosis in the duct-to-duct anastomosis within 90 days. In addition, as part of the research experiment, long-term biliary complications will be assessed, i.e. occurring over a period of more than 90 days (a 2-year observation period of patients was assumed). As part of the trial 284 patients qualified for the procedure of liver transplantation from a deceased donor will be included, in whom end-to-end anastomosis of the bile ducts will be performed. After entering the study, patients will be randomized to one of the groups. In the group of 142 patients, duct-to-duct anastomosis will be performed using an interrupted suture (control group), and the remaining patients will be performed using the continuous suture technique. The analysis will also include surgical complications, complications related to early and late graft function, retransplantation and overall survival. Additionally the analyses an analysis of the impact of the occurrence of a biliary complication on the quality of life of patients after liver transplantation will be performed on the basis of the EORTC QLQ-C30 forms. The period of observation of the patient after the procedure is planned for 24 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 9, 2024
CompletedFirst Posted
Study publicly available on registry
August 1, 2024
CompletedStudy Start
First participant enrolled
September 28, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2028
October 24, 2024
June 1, 2024
2.1 years
July 9, 2024
October 21, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Bile leakage
Defined as bilirubin concentration in the drain fluid at least 3 times the serum bilirubin concentration or as the need for radiologic or operative intervention resulting from biliary collections or bile peritonitis up to 90 days post transplantation
90 days post transplantation
Secondary Outcomes (6)
Critical biliary stricture
90 days post transplantation
Other surgical complications
90 days post transplantation
Long-term biliary complications
2 years post transplantation
Overall survival
2 years post transplantation
Overall graft survival
2 years post transplantation
- +1 more secondary outcomes
Study Arms (2)
Continuous suture technique
EXPERIMENTALBiliary duct-to-duct anastomosis performed with continous suture technique
Interrupted suture
ACTIVE COMPARATORBiliary duct-to-duct anastomosis performed with interrupted suture technique - control group
Interventions
Duct-to-duct anastomosis will be performed using continuous suture technique for study group
Duct-to-duct anastomosis will be performed using an interrupted suture for control group,
Eligibility Criteria
You may qualify if:
- age over 18
- elective liver transplantation
- informed consent to participate in the study
- recipient bile duct diameter over 3mm
- donor bile duct diameter over 3mm
You may not qualify if:
- age below 18
- pregnancy
- living donor liver transplantation
- split-liver or reduced-size liver transplantation
- liver transplantation other than from brain death donor
- liver transplantation with hepaticojejunostomy
- patients undergoing re-transplantation
- multi-organ transplantation
- recipient bile duct diameter below 3mm
- donor bile duct diameter below 3mm
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of General, Transplantation and Liver Surgery UCC MUW
Warsaw, Masovian Voivodeship, 02-097, Poland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 9, 2024
First Posted
August 1, 2024
Study Start
September 28, 2024
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
September 1, 2028
Last Updated
October 24, 2024
Record last verified: 2024-06